Clinical trial
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
NCT00399789 · AEterna Zentaris, Industry · Completed
Key facts
| NCT number | NCT00399789 |
|---|---|
| Title | A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer |
| Official title | A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer |
| Lead sponsor | AEterna Zentaris, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Non Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Perifosine |
| Enrollment | 121 |
| Start date | Sep 1, 2004 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2011 |
| First posted | Nov 15, 2006 |
| Last update posted | Feb 22, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: